This dual hypertrophic-and-hyperplastic mechanism is frequently cited as what distinguishes IGF-1 LR3 from single-pathway anabolic compounds in comparative research
Contact Fella directly for the most current medication options
Competing interests Thomas Thum filed and licensed patents about noncoding RNAs and is founder and CSO/CMO of Cardior Pharmaceuticals GmbH, a wholly owned subsidiary of Novo Nordisk Company
Expect ongoing research, new formulations, and broader applications that could redefine how we approach chronic disease management
One side effect Ive observed with tirzepatide that I have not seen with semaglutide: allodynia, a heightened skin sensitivity where normal touch feels uncomfortable or painful
If you are taking Ozempic or a similar weight-loss drug, or if you plan on losing weight, it is important to exercise and eat a nutritious diet with an emphasis on high protein to combat muscle loss